Assessment of rs1205 and rs1130864 Polymorphisms of C‐Reactive Protein Gene ( CRP ) and Serum CRP Levels in Immune Thrombocytopenia: A Case‐Control Study
Health Science Reports · 2025-09 · 8 (9)
DOI: 10.1002/hsr2.71156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 01.09.2025. Verfasst von Ehsan Sarbazjoda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Thalassemia & Hemoglobinopathy Research Center, Health Research Institute Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ahvaz Jundishapur University of Medical Sciences.
Abstract (Originalsprache)
Background and Aims Immune thrombocytopenia (ITP) is a rare autoimmune disease of platelet destruction with an unclear mechanism of pathogenesis. A well‐known mechanism is the phagocytosis of antibody‐coated platelets by the reticuloendothelial system. C‐reactive protein (CRP) is a factor in the serum of patients, facilitating this process. We aimed to investigate the relationship between rs1205 (+1846 C>T) and rs1130864 (+1444 G>A) polymorphisms, along with their impact on susceptibility, disease course, treatment outcomes, and laboratory findings in ITP.
Methods
Genomic DNA was extracted from 92 participants (46 patients and 46 healthy controls). Both rs1205 and rs1130864 polymorphisms were genotyped by the tetra‐primer amplification refractory mutation system PCR (T‐ARMS‐PCR) procedure. Laboratory and clinical data were also recorded at the time of admission.
Results
The serum CRP levels were significantly higher in nearly all (95.6%) of the patients compared to controls (9.88 ± 3.15 mg/L vs. 5.06 ± 1.07 mg/L, p < 0.001). At a cut‐off of 7.55 mg/L, CRP demonstrated 80.4% sensitivity and 100% specificity. No significant associations were seen regarding the relationship between rs1205 and rs1130864 genotypes/alleles with ITP risk after adjusting the odds ratio for age and sex. There was also no significant association between the two polymorphisms and disease chronicity, response to treatment, and laboratory variables.
Conclusion
In conclusion, findings demonstrate significantly elevated serum CRP levels in nearly all ITP patients, suggesting an inflammatory process in this disease and the diagnostic value of CRP. Moreover, two specific CRP polymorphisms, rs1205 and rs1130864, do not appear to influence ITP susceptibility or clinical outcomes. However, further research is highly recommended.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thalassemia & Hemoglobinopathy Research Center, Health Research Institute Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
- Student Research Committee Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
- Department of Laboratory Sciences, School of Allied Medical Sciences Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
ORCID-Profile: Ehsan Sarbazjoda, Gholam Abbas Kaydani, Mohammad Ali Jalali Far, Kaveh Jaseb, Najmaldin Saki
Förderung
- Ahvaz Jundishapur University of Medical Sciences
Zitieren
APA
Sarbazjoda, E., Kaydani, G. A., Jalali Far, M. A., Jaseb, K., & Saki, N. (2025). Assessment of rs1205 and rs1130864 Polymorphisms of C‐Reactive Protein Gene ( CRP ) and Serum CRP Levels in Immune Thrombocytopenia: A Case‐Control Study. Health Science Reports, 8(9). https://doi.org/10.1002/hsr2.71156
Vancouver
Sarbazjoda E, Kaydani GA, Jalali Far MA, Jaseb K, Saki N. Assessment of rs1205 and rs1130864 Polymorphisms of C‐Reactive Protein Gene ( CRP ) and Serum CRP Levels in Immune Thrombocytopenia: A Case‐Control Study. Health Science Reports. 2025;8(9). doi:10.1002/hsr2.71156
BibTeX
@article{Sarbazjoda2025,
author = {Sarbazjoda, Ehsan and Kaydani, Gholam Abbas and Jalali Far, Mohammad Ali and Jaseb, Kaveh and Saki, Najmaldin},
title = {Assessment of rs1205 and rs1130864 Polymorphisms of C‐Reactive Protein Gene ( CRP ) and Serum CRP Levels in Immune Thrombocytopenia: A Case‐Control Study},
journal = {Health Science Reports},
year = {2025},
volume = {8},
number = {9},
doi = {10.1002/hsr2.71156}
}
EUVIMED